PARIS — By assessing residual regurgitation after a transcatheter tricuspid valve repair with a four-grade rather than three-grade system, physicians can predict survival more accurately, reported ...

Background Recurrent mitral regurgitation (MR) remains a major limitation of mitral valve (MV) repair in patients with ...

The findings provide contemporary surgical benchmarks, which will become even more important as M-TEER trial data emerge.

Cardiac experts from Pittsburgh's Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) announced today they are the first in the region and among the first in the state to successfully ...

Investigators with the Smidt Heart Institute at Cedars-Sinai have developed an artificial intelligence (AI) program to detect the presence and severity of mitral valve regurgitation, the most common ...

Heart with coronary vessels inside human body, computer illustration. Patients who have truncus arteriosus with moderate or worse initial truncal valve regurgitation or stenosis may be at risk for ...

Please provide your email address to receive an email when new articles are posted on . In patients who had mitral valve surgery but also tricuspid regurgitation or tricuspid annular dilation, ...

JACKSONVILLE, Fla. – News4JAX meteorologist Katie Garner opened up to viewers Friday about her recent heart condition diagnosis. Katie was diagnosed with Mitral valve prolapse with regurgitation, also ...

WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A transapical transcatheter mitral valve repair system ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...